Radiotherapy in Patients With Metastatic Esophageal Cancer Responding to PD-1 Inhibitor Plus Chemotherapy
Abroad (travel likely)RecruitingPHASE2
Conditions
Esophageal Neoplasm Metastatic · Esophageal Cancer Stage IVb
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Cancer hospital, CAMS, Beijing, Beijing Municipality, China
Contact: Principal Investigator (Wen-Yang Liu)
Study leads
Wen-Yang Liu, MD
Principal Investigator
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Zhi-Hao Lu, MD
Principal Investigator
Peking University Cancer Hospital & Institute